Codes / ICD10CM / M1A.261

M1A.261 Drug-induced chronic gout, right knee

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Right Knee

Summary

Drug-induced chronic gout, right knee is a form of arthritis affecting the right knee joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right knee joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense right knee pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected knee
  • Formation of tophi (hard, painless lumps) around the knee joint
  • Stiffness and limited range of motion in the right knee
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis confirms urate crystal presence. Imaging (e.g., X-ray, ultrasound) assesses joint damage and tophi. The right knee is specifically evaluated to confirm site involvement.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatories for flare-ups. Lifestyle modifications, such as dietary changes, support management. In severe cases, tophi removal or joint surgery may be considered.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up monitors uric acid levels and treatment efficacy. Untreated cases risk progressive joint damage and disability. Adherence to medication and lifestyle changes improves outcomes.

Complications

  • Chronic joint damage or deformity in the right knee
  • Formation of large tophi causing functional impairment
  • Increased risk of kidney stones or renal impairment
  • Recurrent flare-ups leading to reduced mobility

Lifestyle & Prevention

  • Avoid medications known to raise uric acid (if possible, under medical guidance)
  • Maintain a balanced diet low in purines (e.g., limit red meat, alcohol)
  • Stay hydrated to support uric acid excretion
  • Manage weight and exercise regularly to reduce joint stress

When to Seek Professional Help

Seek care if experiencing severe or worsening right knee pain, swelling, or stiffness. Prompt evaluation is needed for sudden flare-ups or signs of infection (e.g., fever, redness). Regular check-ups are recommended for ongoing management.

Tips for Medical Coders

Document the specific site (right knee) and confirm drug-induced etiology. Ensure clinical notes support the diagnosis, including medication history and joint involvement. Code M1A.261 is specific to the right knee; verify no other site is documented to avoid miscoding.

Book a walkthrough

M1A.261 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.